TAS2R30 IDG GPCR ARCHS4 coexpression (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with TAS2R30 IDG GPCR ARCHS4 coexpression.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with TAS2R30 IDG GPCR ARCHS4 coexpression.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with TAS2R30 IDG GPCR ARCHS4 coexpression.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with TAS2R30 IDG GPCR ARCHS4 coexpression.

Results found

Linked to

 

Label

Description

 

Gene

zinc finger protein 37B, pseudogene

Gene

ankyrin repeat domain 36B pseudogene 2

Gene

SMG1 pseudogene 3

Gene

major histocompatibility complex, class I, L (pseudogene)

Gene

SMG1 pseudogene 1

Gene

CCDC144A N-terminal like (pseudogene)

Gene

glycogenin 2 pseudogene 1

Gene

SMG1 pseudogene 5

Gene

DIP2C antisense RNA 1

Gene

long intergenic non-protein coding RNA 2898

  • Gene

    zinc finger protein 37B, pseudogene


  • Gene

    ankyrin repeat domain 36B pseudogene 2


  • Gene

    SMG1 pseudogene 3


  • Gene

    major histocompatibility complex, class I, L (pseudogene)


  • Gene

    SMG1 pseudogene 1


  • Gene

    CCDC144A N-terminal like (pseudogene)


  • Gene

    glycogenin 2 pseudogene 1


  • Gene

    SMG1 pseudogene 5


  • Gene

    DIP2C antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 2898

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.